ImmPort Ontology Conference: Difference between revisions
Line 60: | Line 60: | ||
== <u>Thursday, September 5, 2013</u> == | == <u>Thursday, September 5, 2013</u> == | ||
Major Questions for Discussion: | |||
Notes on topics and goals: | |||
The ontological landscape of immunology: perusing terms, concepts and protocol descriptions | |||
* Extreme case: no nomenclature standard for cytokines | |||
* Less extreme case: "standard" principal name in immunology frequently not the principal name used in the rest of biology --> consequence | |||
How other areas of biology have handled some of these issues: from funcky gene names to coherent naming schemes. Surely immunology can do the same | |||
* Why bother? When terms are so ill-defined or mis-used as in immunology, synonyms aren't necessarily a solution | |||
Provide example use cases compromised by nomenclature chaos: | |||
relating FCM phenotyping to gene expression: hard to relate CD86 on the FCM measurement side to integrin XXX on the gene expression side, because no repository follows immuno principal naming. And that's not taking into account all the synonyms on the immunological side | |||
How key ontologies can help immunology | |||
CL, PRO: assigning cell populations to well-defined concepts to facilitate exchange and enable computation | |||
OBI: describing protocols and assays | |||
other? | |||
Revision as of 18:58, 26 June 2013
Where: Stanford University
When: September 4-5, 2013
Audience: The conference is divided into two parts. Day 1 is intended for all those engaged in information-driven immunology research who have an interest in ontology and data standardization; Day 2 is intended also to provide training for those interested in acquiring skills needed for working with ontologies to solve specific problems.
Participation: There is a limited number of places available for this meeting. If you are interested in attending please contact Barry Smith as soon as possible.
Goals
Day 1: Sept 4
- demonstrate to bench immunologists that their nomenclature schemes need to evolve to support enhanced discoverability and reusability (thus use of standards and ontologies)
- provide arguments and success stories that will help to achieve buy-in from bench immunologists as to the importance of standards and ontologies
- provide examples of ontology content and of good practice use of ontologies which will help immunologists to rationalize their nomenclature and help them understand how ontologies are applied
Day 2: Sept 5 – restricted meeting – ImmPort and invitees only
- go through the steps of the ontological process involved in handling CyTOF data
- identify immunology science issues for which new ontology content will be required; in particular:
- address the workflow which leads from CyTOF data to identification of cell types using the CL ontology
- address how to deal with PPCs in an ontological manner, e.g., using a code to handle the experimental protocol through which the PPC was identified
Critical attendance
- people from CyTOF world
Background
An overview of ontologies proposed by ImmPort for use across the immunology research community
Wednesday, September 4, 2013
8:30 Registration and Continental Breakfast
9:00 What Benefits Can Ontology Bring to the DAIT Research Community?
- Overview by Barry Smith
10:15 Break
10:30 ImmPort Ontologies
12:00 Lunch
13:00 Flow Cytometry
- Courtot/Brinkman: http://ontology.buffalo.edu/pro/CytometryOntologyFramework.pdf The Cytometry-Ontology Framework]
- PRO, CL and CyTOF
15:00 Break
15:30 Shai Shen-Orr: Ontology, NLP and the Semantic Enhancement of Immunology Research Literature
16:30 Lindsay Cowell: Immunology Ontology and NLP
Thursday, September 5, 2013
Major Questions for Discussion:
Notes on topics and goals: The ontological landscape of immunology: perusing terms, concepts and protocol descriptions
- Extreme case: no nomenclature standard for cytokines
- Less extreme case: "standard" principal name in immunology frequently not the principal name used in the rest of biology --> consequence
How other areas of biology have handled some of these issues: from funcky gene names to coherent naming schemes. Surely immunology can do the same
- Why bother? When terms are so ill-defined or mis-used as in immunology, synonyms aren't necessarily a solution
Provide example use cases compromised by nomenclature chaos: relating FCM phenotyping to gene expression: hard to relate CD86 on the FCM measurement side to integrin XXX on the gene expression side, because no repository follows immuno principal naming. And that's not taking into account all the synonyms on the immunological side How key ontologies can help immunology CL, PRO: assigning cell populations to well-defined concepts to facilitate exchange and enable computation OBI: describing protocols and assays other?
8:30 Continental Breakfast
9:00 An Introduction to Ontology for CyTOF
9:30 An Introduction to Immunology for CyTOF
10:00 Immunology in the Gene Ontology (Alexander Diehl)
10:30 CL
11:00 PRO
12:00 Lunch
13:00 CyTOF to CL Workflow
16:00 Close
Participants (* = tentative)
- Ryan Brinkman (Vancouver, BC)
- Lindsay Cowell (UT Southwestern, Dallas)
- Melanie Courtot (Vancouver, BC)
- Alexander Diehl (ImmPort / Buffalo)
- Sanda Harabagiu (UT Southwestern, Dallas)
- Nikesh Kotecha (Stanford)
- Yannick Pouliot (ImmPort / Stanford)
- Alan Ruttenberg (ImmPort / Buffalo)
- Ravi Shankar (ImmPort / Stanford)
- Shai Shen-Orr (ImmPort / Technion Institute)
- Barry Smith (ImmPort / Buffalo)
- *Representatives of institutions supplying data to ImmPort
- *Representatives of companies selling (for example) analytes
Plus participants from Stanford area